de la Camara R

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT.

Ghorashian S, Malard F, Yüksel MK, ..., Ruggeri A, Chabannon C

Bone Marrow Transplant - (-) - [2021-11-20; online 2021-11-20]

Type: Other

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Spanjaart AM, Ljungman P, de La Camara R, ..., Kersten MJ, Mielke S

Leukemia - (-) - [2021-11-08; online 2021-11-08]

Category: Health Type: Journal article